• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS COBAS B 123 <4> SYSTEM; BLOOD GAS ANALYZER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS COBAS B 123 <4> SYSTEM; BLOOD GAS ANALYZER Back to Search Results
Catalog Number 05122279001
Device Problem Low Test Results (2458)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 03/21/2018
Event Type  malfunction  
Manufacturer Narrative
Unique identifier (udi)#: (b)(4).This event occurred in (b)(6).(b)(6).
 
Event Description
The customer received questionable ionized calcium (ca2+) results for one patient.The patient was under "hemo-filtration treatment in icu" therefore the patient's blood contained citric acid as an anti-coagulant which may have affected the results.The results from the cobas b123 were <0.1 mmol/l and 1.069 mmol/l.On (b)(6) 2018, the result was <0.1 mmol/l with a data flag.The results from a cobas b221 analyzer were 0.250 mmol/l with a data flag and 1.263 mmol/l.On (b)(6) 2018, the result was 0.217 mmol/l with a data flag, no erroneous result was reported outside of the laboratory.There was no allegation of an adverse event.The reagent lot number and expiration date were requested but were not provided.As part of troubleshooting, the customer performed comparison testing between the cobas b123 and cobas b221 using heparin, citric acid, and blood gas needles as the anti-coagulant.The qc results for each analyzer were acceptable.
 
Manufacturer Narrative
The investigation found the customer's use of citric acid as an anti-coagulant was the cause of the issue.Product labeling states heparin salts are the only permitted anticoagulants for analyses in the cobas b 123 poc system.Other anticoagulants, such as edta, citrate, oxalates, fluorides and ammonia-containing anticoagulants have a significant effect on the blood ph value and other parameters and thus must not be used.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
COBAS B 123 <4> SYSTEM
Type of Device
BLOOD GAS ANALYZER
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
MDR Report Key7421633
MDR Text Key105768784
Report Number1823260-2018-01127
Device Sequence Number1
Product Code CHL
Combination Product (y/n)N
PMA/PMN Number
K111188
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Type of Report Initial,Followup
Report Date 04/26/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number05122279001
Was Device Available for Evaluation? Yes
Initial Date Manufacturer Received 03/21/2018
Initial Date FDA Received04/11/2018
Supplement Dates Manufacturer Received03/21/2018
Supplement Dates FDA Received04/26/2018
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-